Repligen
RGEN
#2379
Rank
โ‚น764.69 B
Marketcap
โ‚น13,556
Share price
2.45%
Change (1 day)
25.15%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): โ‚น7.35 Billion

According to Repligen 's latest financial reports the company's current earnings are โ‚น0.73 Billion. , an increase over its 2024 earnings that were of -โ‚น0.61 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น7.98 B-1430.84%
2024 -โ‚น0.61 Billion-113.01%
2023 โ‚น4.61 B-78.01%
2022 โ‚น20.97 B33.37%
2021 โ‚น15.72 B131.52%
2020 โ‚น6.79 B101.31%
2019 โ‚น3.37 B25.93%
2018 โ‚น2.67 B105.61%
2017 โ‚น1.30 B-11.46%
2016 โ‚น1.47 B14.91%
2015 โ‚น1.28 B20.26%
2014 โ‚น1.06 B-51.49%
2013 โ‚น2.19 B90.98%
2012 โ‚น1.14 B
2010 โ‚น16.66 M-103.81%
2009 -โ‚น0.44 Billion-223.84%
2008 โ‚น0.35 B
2006 -โ‚น0.24 Billion229.64%
2005 -โ‚น71.87 Million-89.16%
2004 -โ‚น0.67 Billion-16.86%
2003 -โ‚น0.8 Billion88.72%
2002 -โ‚น0.43 Billion-27.88%
2001 -โ‚น0.59 Billion-1.74%
2000 -โ‚น0.6 Billion85.93%
1999 -โ‚น0.33 Billion159.16%
1998 -โ‚น0.13 Billion85.71%
1997 -โ‚น66.64 Million-70.83%
1996 -โ‚น0.23 Billion-72.41%
1995 -โ‚น0.83 Billion-60.63%
1994 -โ‚น2.11 Billion45.39%
1993 -โ‚น1.45 Billion39.45%
1992 -โ‚น1.04 Billion-32.3%
1991 -โ‚น1.54 Billion6.62%
1990 -โ‚น1.44 Billion1577.78%
1989 -โ‚น85.68 Million-57.14%
1988 -โ‚น0.2 Billion-362.5%
1987 โ‚น76.15 M-130.77%
1986 -โ‚น0.25 Billion136.36%
1985 -โ‚น0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.008 T 12,523.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น706.57 B 8,746.67%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น1.045 T 12,988.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น913.63 B 11,339.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น10.38 Billion-229.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น44.24 B 453.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น76.04 B 852.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น11.75 B 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น36.70 B 359.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-โ‚น9.48 Billion-218.60%๐Ÿ‡บ๐Ÿ‡ธ USA